Salum GA, DeSousa DA, do Rosário MC, Pine DS, Manfro GG. Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice. Rev Bras Psiquiatr. 2013;35:S03-21.

Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009;32:483-524.

Beesdo-Baum K, Knappe S, Fehm L, Höfler M, Lieb R, Hofmann SG. The natural course of social anxiety disorder among adolescents and young adults. Acta Psychiatr Scand. 2012;126:411-25.

Rockhill C, Kodish I, DiBattisto C, Macias M, Varley C, Ryan S. Anxiety disorders in children and adolescents. Curr Probl Pediatr Adolesc Health Care. 2010;40:66-99.

Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43:897-910.

Hettema JM1, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568-78.

Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33-41.

Laucht M, Treutlein J, Blomeyer D, Buchmann AF, Schmid B, Becker K. Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. Int J Neuropsychopharmacol. 2009;12:737-47.

Petersen IT, Bates JE, Goodnight JA, Dodge KA, Lansford JE, Pettit GS. Interaction between serotonin transporter polymorphism (5-HTTLPR) and stressful life events in adolescents' trajectories of anxious/depressed symptoms. Dev Psychol. 2012;48:1463-75.

de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463-75.

Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation. 2009;16:340-52.

Baes Cv, Martins CM, Tofoli SM, Juruena MF. Early life stress in depressive patients: HPA Axis response to GR and MR agonist. Front Psychiatry. 2014;5:2.

Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284:592-7.

Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008;33:693-710.

Dempster EL, Burcescu I, Wigg K, Kiss E, Baji I, Gadoros J. Further genetic evidence implicates the vasopressin system in childhood-onset mood disorders. Eur J Neurosci. 2009;30:1615-9.

Shea A, Walsh C, Macmillan H, Steiner M. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology. 2005;30:162-78.

Pawlak R, Magarinos AM, Melchor J, McEwen B, Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci. 2003;6:168-74.

Harris a P, Holmes MC, de Kloet ER, Chapman KE, Seckl JR. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology. 2013;38:648-58.

Derijk RH, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol. 2008;583:303-11.

Irving JA, Pike RN, Lesk AM, Whisstock JC. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 2000;10:1845-64.

Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Rajewska-Rager A, Dmitrzak-Weglarz M, Wilkosc M. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. J Affect Disord. 2011;134:138-44.

Leszczynska-Rodziewicz A, Szczepankiewicz A, Dmitrzak-Weglarz M, Rajewska-Rager A, Skibinska M, Hauser J. No association between polymorphisms and haplotypes of the AVPR1b, CRHR1 and NR3C1 genes and depression with melancholic features in the course of bipolar disorder. Psychiatry Res. 2013;207:140-2.

Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 Is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141:4107-13.

Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009;34:S186-95.

Roy A, Gorodetsky E, Yuan Q, Goldman D, Enoch MA. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology. 2010;35:1674-83.

Bevilacqua L, Carli V, Sarchiapone M, George DK, Goldman D, Roy A. Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch Gen Psychiatry. 2012;69:62-70.

Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry. 2011;168:1107-16.

Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36:1319-25.

Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci. 2008;28:389-98.

Smoller JW, Rosenbaum JF, Biederman J, Kennedy J, Dai D, Racette SR. Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry. 2003;54:1376-81.

Müller MB, Wurst W. Getting closer to affective disorders: the role of CRH receptor systems. Trends Mol Med. 2004;10:409-15.

Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet. 1998;19:162-6.

Salum GA, Isolan LR, Bosa VL, Tocchetto AG, Teche SP, Schuch I. The multidimensional evaluation and treatment of anxiety in children and adolescents: rationale, design, methods and preliminary findings. Rev Bras Psiquiatr. 2011;33:181-95.

Isolan L, Salum GA, Osowski AT, Amaro E, Manfro GG. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED) in Brazilian children and adolescents. J Anxiety Disord. 2011;25:741-8.

Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P. Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-8.

Polanczyk G V, Eizirik M, Aranovich V, Denardin D, da Silva TL, da Conceição TV. Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E). Rev Bras Psiquiatr. 2003;25:87-90.

Tocchetto A, Salum GA, Blaya C, Teche S, Isolan L, Bortoluzzi A. Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neurosci Lett. 2011;502:197-200.

Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, da Rosa ED. Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. J Psychiatr Res. 2014;59:8-13.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-75.

Minelli A, Maffioletti E, Cloninger CR, Magri C, Sartori R, Bortolomasi M. Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. Depress Anxiety. 2013;30:1170-6.

Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS. Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry. 2009;14:261-8.

Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology. 2010;35:1684-92.

Buchmann AF, Holz N, Boecker R, Blomeyer D, Rietschel M, Witt SH. Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood. Eur Neuropsychopharmacol. 2014;24:837-45.

Lavebratt C, Aberg E, Sjöholm LK, Forsell Y. Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord. 2010;125:249-55.

Tsai SJ, Hong CJ, Chen TJ, Yu YW. Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:1097-8.

Gawlik M, Moller-Ehrlich K, Mende M, Jovnerovski M, Jung S, Jabs B. Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits. BMC Psychiatry. 2006;6:52.

Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Narozna B, Rajewska-Rager A, Wilkosc M. FKBP5 polymorphism is associated with major depression but not with bipolar disorder. J Affect Disord. 2014;164:33-7.

Spijker AT, Giltay EJ, van Rossum EF, Manenschijn L, DeRijk RH, Haffmans J. Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients. Psychoneuroendocrinology. 2011;36:1460-9.

Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, Salyakina D. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1196-204.

Heitland I, Groenink L, Bijlsma EY, Oosting RS, Baas JM. Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter. PLoS One. 2013;8:e63772.

Waters AM, Peters RM, Forrest KE, Zimmer-Gembeck M. Fear acquisition and extinction in offspring of mothers with anxiety and depressive disorders. Dev Cogn Neurosci. 2014;7:30-42.

Holliday KL, Macfarlane GJ, Nicholl BI, Creed F, Thomson W, McBeth J. Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. J Psychosom Res. 2010;68:469-74.

Eiland L, Romeo RD. Stress and the developing adolescent brain. Neuroscience. 2013;249:162-71.